HCAT Key Statistics, Chart & Performance
The current stock price of HCAT is 2.81 USD. In the past month the price decreased by -18.05%. In the past year, price decreased by -68.63%.
HCAT Latest News, Press Relases and Analysis
HCAT Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| VEEV | VEEVA SYSTEMS INC-CLASS A | 31.25 | 39.64B | ||
| DOCS | DOXIMITY INC-CLASS A | 31.25 | 9.60B | ||
| WAY | WAYSTAR HOLDING CORP | 27.69 | 7.08B | ||
| HTFL | HEARTFLOW INC | N/A | 2.65B | ||
| CERT | CERTARA INC | 18.22 | 1.45B | ||
| TDOC | TELADOC HEALTH INC | N/A | 1.32B | ||
| SDGR | SCHRODINGER INC | N/A | 1.29B | ||
| PHR | PHREESIA INC | N/A | 1.21B | ||
| LFMDP | LIFEMD INC - LFMD 8 7/8 PERP | N/A | 1.12B | ||
| CCLDO | CARECLOUD INC - CCLD 8 3/4 PERP | 627 | 1.06B | ||
| GDRX | GOODRX HOLDINGS INC-CLASS A | 8.03 | 953.80M | ||
| CTEV | CLARITEV CORP | N/A | 889.64M |
Related stock screener links
About HCAT
Company Profile
Health Catalyst, Inc. engages in the provision of data and analytics technology and services to healthcare organizations. The company is headquartered in South Jordan, Utah. The company went IPO on 2019-07-25. The firm's solution comprises its cloud-based data platform, applications, and expertise. Its segments include Technology and Professional Services. The Technology segment includes its data platform, analytics applications and support services and earns primarily from contracts that are cloud-based subscription arrangements, time-based license arrangements, and maintenance and support fees. The Professional Services segment is generally a combination of analytics, implementation, strategic advisory, outsourcing, and improvement services to deliver capabilities to its clients to fully configure and utilize the benefits of its technology offerings. Its clients, which are primarily healthcare providers, use its Solution to manage their data, derive analytical insights to operate their organization, and produce measurable clinical, financial, and operational improvements.
Company Info
HEALTH CATALYST INC
10897 South River Front Parkway, #300
South Jordan UTAH 84121 US
CEO: Daniel Burton
Employees: 1500
Phone: 18017086800
HEALTH CATALYST INC / HCAT FAQ
What does HCAT do?
Health Catalyst, Inc. engages in the provision of data and analytics technology and services to healthcare organizations. The company is headquartered in South Jordan, Utah. The company went IPO on 2019-07-25. The firm's solution comprises its cloud-based data platform, applications, and expertise. Its segments include Technology and Professional Services. The Technology segment includes its data platform, analytics applications and support services and earns primarily from contracts that are cloud-based subscription arrangements, time-based license arrangements, and maintenance and support fees. The Professional Services segment is generally a combination of analytics, implementation, strategic advisory, outsourcing, and improvement services to deliver capabilities to its clients to fully configure and utilize the benefits of its technology offerings. Its clients, which are primarily healthcare providers, use its Solution to manage their data, derive analytical insights to operate their organization, and produce measurable clinical, financial, and operational improvements.
What is the current price of HCAT stock?
The current stock price of HCAT is 2.81 USD. The price increased by 1.44% in the last trading session.
What is the dividend status of HEALTH CATALYST INC?
HCAT does not pay a dividend.
How is the ChartMill rating for HEALTH CATALYST INC?
HCAT has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
What is the expected growth for HCAT stock?
The Revenue of HEALTH CATALYST INC (HCAT) is expected to grow by 1.83% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.
What is the employee count for HCAT stock?
HEALTH CATALYST INC (HCAT) currently has 1500 employees.
When does HEALTH CATALYST INC (HCAT) report earnings?
HEALTH CATALYST INC (HCAT) will report earnings on 2026-02-24, after the market close.
HCAT Technical Analysis
HCAT Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to HCAT. HCAT may be in some trouble as it scores bad on both profitability and health.
HCAT Financial Highlights
Over the last trailing twelve months HCAT reported a non-GAAP Earnings per Share(EPS) of 0.15. The EPS decreased by -42.31% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -18.33% | ||
| ROE | -32.42% | ||
| Debt/Equity | 0.46 |
HCAT Forecast & Estimates
18 analysts have analysed HCAT and the average price target is 4.02 USD. This implies a price increase of 43.18% is expected in the next year compared to the current price of 2.81.
For the next year, analysts expect an EPS growth of -19.86% and a revenue growth 1.83% for HCAT